Improvements in quality of life of patients with multiple sclerosis receiving alemtuzumab in clinical practice: the LEMVIDA study.
Saved in:
| Title: | Improvements in quality of life of patients with multiple sclerosis receiving alemtuzumab in clinical practice: the LEMVIDA study. |
|---|---|
| Authors: | Meca-Lallana JE; Multiple Sclerosis CSUR, Neurology Department, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain. pmecal@gmail.com.; Clinical Neuroimmunology and Multiple Sclerosis Department, UCAM, Universidad Católica San Antonio, Murcia, Spain. pmecal@gmail.com., Eichau S; Neuroimmunology Unit, Hospital Virgen Macarena, Sevilla, Spain., Casanova B; Hospital Universitari i Politècnic La Fe, Valencia, Spain., Rodríguez EÁ; Hospital Álvaro Cunqueiro, Vigo, Spain., Pato A; Hospital Povisa, Vigo, Spain., Forner M; Sanofi, Barcelona, Spain., Toledo B; Sanofi, Barcelona, Spain. |
| Source: | Journal of patient-reported outcomes [J Patient Rep Outcomes] 2024 Dec 18; Vol. 8 (1), pp. 148. Date of Electronic Publication: 2024 Dec 18. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Springer International Publishing Country of Publication: Germany NLM ID: 101722688 Publication Model: Electronic Cited Medium: Internet ISSN: 2509-8020 (Electronic) Linking ISSN: 25098020 NLM ISO Abbreviation: J Patient Rep Outcomes Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
